Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

NK cells promote islet allograft tolerance via a perforin-dependent mechanism

Nature Medicine volume 11, pages 1059–1065 (2005)Cite this article

A Corrigendum to this article was published on 01 March 2006

This article has been updated

Abstract

Although major histocompatibility complex (MHC) class II–restricted CD4 T cells are well appreciated for their contribution to peripheral tolerance to tissue allografts, little is known regarding MHC class I–dependent reactivity in this process. Here we show a crucial role for host MHC class I–dependent NK cell reactivity for allograft tolerance in mice induced through either costimulation blockade using CD154-specific antibody therapy or by targeting LFA-1 (also known as CD11a). Tolerance induction absolutely required host expression of MHC class I, but was independent of CD8 T cell–dependent immunity. Rather, tolerance required innate immunity involving NK1.1+ cells, but was independent of CD1d-restricted NKT cells. Therefore, NK cells seem to be generally required for induction of tolerance to islet allografts. Additional studies indicate that CD154-specific antibody–induced allograft tolerance is perforin dependent. Notably, NK cells that are perforin competent are sufficient to restore allograft tolerance in perforin-deficient recipients. Together, these results show an obligatory role for NK cells, through perforin, for induction of tolerance to islet allografts.

Note: In the version of this article initially published, the authors inadvertently misquoted a study as evidence that mouse NKT cells can express CD154 (ref. 29). Rather, the cited study concerned CD40-CD40L interactions in human NK cells. By misquoting this study, the authors also omitted an appropriate reference regarding prior evidence of CD40-CD40L interactions by murine NKT cells (Kitamura, H. et al., J. Exp. Med. 189, 1121; 1999). These errors have been corrected in the PDF version.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: MHC class I–deficient recipients are resistant to allograft tolerance.
Figure 2: NK1.1+ cells are required for allograft tolerance.
Figure 3: NKT cells are not required for allograft tolerance.
Figure 4: CD154-specific monoclonal antibody–induced alterations in lymphocyte populations require NK cells.
Figure 5: Perforin-competent NK cells restore tolerance in perforin-deficient (PFPKO) recipients.

Similar content being viewed by others

Change history

  • 24 February 2006

    Note: In the version of this article initially published, the authors inadvertently misquoted a study as evidence that mouse NKT cells can express CD154 (ref. 29). Rather, the cited study concerned CD40-CD40L interactions in human NK cells. By misquoting this study, the authors also omitted an appropriate reference regarding prior evidence of CD40-CD40L interactions by murine NKT cells (Kitamura, H. et al., J. Exp. Med. 189, 1121; 1999). These errors have been corrected in the PDF version.

References

  1. Wood, K.J. & Sakaguchi, S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3, 199–210 (2003).

    Article  CAS  PubMed  Google Scholar 

  2. Gilliet, M. & Liu, Y. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695–704 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Zhou, J., Carr, R.I., Liwski, R.S., Stadnyk, A.W. & Lee, T.D. Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J. Immunol. 167, 107–113 (2001).

    Article  CAS  PubMed  Google Scholar 

  4. Ciubotariu, R. et al. Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28− regulatory T cells. J. Immunol. 161, 5193–5202 (1998).

    CAS  PubMed  Google Scholar 

  5. Le Moine, A. & Goldman, M. Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction? Am. J. Transplant. 3, 101–106 (2003).

    Article  CAS  PubMed  Google Scholar 

  6. Seino, K. et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl. Acad. Sci. USA 98, 2577–2581 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sonoda, K., Taniguchi, M. & Stein-Streilein, J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J. Immunol. 168, 2028–2034 (2002).

    Article  CAS  PubMed  Google Scholar 

  8. Yokoyama, W.M., Kim, S. & French, A.R. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22, 405–429 (2004).

    Article  CAS  PubMed  Google Scholar 

  9. Raulet, D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5, 996–1002 (2004).

    Article  CAS  PubMed  Google Scholar 

  10. Lantz, O. & Bendelac, A. An invariant T cell receptor a chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4−8− T cells in mice and humans. J. Exp. Med. 180, 1097–1106 (1994).

    Article  CAS  PubMed  Google Scholar 

  11. Kronenberg, M. & Gapin, L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2, 557–568 (2002).

    Article  CAS  PubMed  Google Scholar 

  12. Godfrey, D.I., MacDonald, R., Kronenberg, M., Smyth, M.J. & Van Kaer, L. NKT cells: what's in a name? Nat. Rev. Immunol. 4, 231–237 (2004).

    Article  CAS  PubMed  Google Scholar 

  13. Moretta, A. Natural killer cells and dendritic cells: rendezvous in abused tisues. Nat. Rev. Immunol. 2, 957–964 (2002).

    Article  CAS  PubMed  Google Scholar 

  14. Kondo, T. et al. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation 69, 969–977 (2000).

    Article  CAS  PubMed  Google Scholar 

  15. Sun, W. et al. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production. Immunol. Lett. 94, 191–199 (2004).

    Article  CAS  PubMed  Google Scholar 

  16. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. & Wakao, H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21, 483–513 (2003).

    Article  CAS  PubMed  Google Scholar 

  17. Van Kaer, L. Regulation of immune responses by CD1d-restricted natural killer T cells. Immunol. Res. 30, 139–153 (2004).

    Article  CAS  PubMed  Google Scholar 

  18. Piccioli, D., Sbrana, S., Melandri, E. & Valiante, N.M. Contact-dependent stimulation and inibition of dendritic cells by natural killer cells. J. Exp. Med. 195, 335–341 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ferlazzo, G. et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 33, 306–313 (2003).

    Article  CAS  PubMed  Google Scholar 

  20. Hayakawa, Y. et al. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J. Immunol. 172, 123–129 (2004).

    Article  CAS  PubMed  Google Scholar 

  21. Pietra, G. et al. Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells. Eur. J. Immunol. 33, 3427–3432 (2003).

    Article  CAS  PubMed  Google Scholar 

  22. Dowdell, K.C., Cua, D.J., Kirkman, E. & Stohlman, S.A. NK cells regulate CD4 responses prior to antigen encounter. J. Immunol. 171, 234–239 (2003).

    Article  CAS  PubMed  Google Scholar 

  23. Vankayalapati, R. et al. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J. Immunol. 172, 130–137 (2004).

    Article  CAS  PubMed  Google Scholar 

  24. Nicolls, M.R., Coulombe, M., Beilke, J., Gelhaus, H.C. & Gill, R.G. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J. Immunol. 169, 4831–4839 (2002).

    Article  PubMed  Google Scholar 

  25. Koller, B.H., Marrack, P., Kappler, J.W. & Smithies, O. Normal development of mice deficient in β2M, MHC class I proteins, and CD8+ T cells. Science 248, 1227–1230 (1990).

    Article  CAS  PubMed  Google Scholar 

  26. Liao, N.S., Bix, M., Zijlstra, M., Jaenisch, R. & Raulet, D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253, 199–202 (1991).

    Article  CAS  PubMed  Google Scholar 

  27. Zhai, Y., Meng, L., Busuttil, R.W., Sayegh, M.H. & Kupiec-Weglinski, J.W. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive. J. Immunol. 170, 3024–3028 (2003).

    Article  CAS  PubMed  Google Scholar 

  28. Van Kaer, L., Ashton-Rickardt, P.G., Ploegh, H.L. & Tonegawa, S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells. Cell 71, 1205–1214 (1992).

    Article  CAS  PubMed  Google Scholar 

  29. Carbone, E. et al. A new mechanism of NK cell cytotoxicity activation: the CD40–CD40 ligand interaction. J. Exp. Med. 185, 2053–2060 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Ljunggren, H.G. & Karre, K. In search of the 'missing self': MHC molecules and NK cell reconition. Immunol. Today 11, 237–244 (1990).

    Article  CAS  PubMed  Google Scholar 

  31. Coudert, J.D., Coureau, C. & Guery, J.C. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens. J. Immunol. 169, 2979–2987 (2002).

    Article  CAS  PubMed  Google Scholar 

  32. Sha, W.C. et al. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336, 73–76 (1988).

    Article  CAS  PubMed  Google Scholar 

  33. Bose, A., Inoue, Y., Kokko, K.E. & Lakkis, F.G. Cutting edge: perforin down-regulates CD4 and CD8 T cell-mediated immune responses to a transplanted organ. J. Immunol. 170, 1611–1614 (2003).

    Article  CAS  PubMed  Google Scholar 

  34. Rabinovich, B.A. et al. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170, 3572–3576 (2003).

    Article  CAS  PubMed  Google Scholar 

  35. Trambley, J. et al. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104, 1715–1722 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Fort, M.M., Leach, M.W. & Rennick, D.M. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J. Immunol. 161, 3256–3261 (1998).

    CAS  PubMed  Google Scholar 

  37. Maier, S. et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28−/− mice. Nat. Med. 7, 557–562 (2001).

    Article  CAS  PubMed  Google Scholar 

  38. Degli-Esposti, M.A. & Smyth, M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5, 112–124 (2005).

    Article  CAS  PubMed  Google Scholar 

  39. Mendiratta, S.K. et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6, 469–477 (1997).

    Article  CAS  PubMed  Google Scholar 

  40. Matsuda, J.L. et al. Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA 100, 8395–8400 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank L. Gapin for experimental advice, T. Rubtsov for technical support and M. Sleater for critical review of the manuscript.

Author information

Authors and Affiliations

  1. Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 1775 Ursula Street, Box B-140, Aurora, 80010, Colorado, USA

    Joshua N Beilke, Nathan R Kuhl & Ronald G Gill

  2. Department of Microbiology and Immunology, Vanderbilt University School of Medicine, 1161 21st Avenue South, Nashville, 37232, Tennessee, USA

    Luc Van Kaer

Authors
  1. Joshua N Beilke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nathan R Kuhl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luc Van Kaer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ronald G Gill
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ronald G Gill.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

NK and NKT cell activity increase in animals deficient in other class I pathways. (PDF 97 kb)

Supplementary Fig. 2

Anti-CD154 treatment permits NK cell killing and NKT cell IL-4 production. (PDF 83 kb)

Supplementary Table 1

CD8 T cells are not required for anti-CD154 induced allograft tolerance. (PDF 33 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beilke, J., Kuhl, N., Kaer, L. et al. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 11, 1059–1065 (2005). https://doi.org/10.1038/nm1296

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1296

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing